NCT01225081View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

September 15, 2010

Primary Completion Date

April 28, 2012

Study Completion Date

April 28, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

DRUG

Placebo

oral

DRUG

Pioglitazone

oral

Trial Locations (7)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY